Fang‐Shu Ou

Also affiliated with Alliance for Clinical Trials in Oncology, Quantitative BioSciences, Mayo Clinic in Arizona, Alliance Data (United States), Mayo Clinic in Florida

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)

(2023)10.1158/1078-0432.c.6529877

Top 100%

0DataRank

Top 100%0 citations

Alexander B. Sibley, Sushant Patil, Amy S. Etheridge, Chen Jiang, Fang‐Shu Ou +15 more

Papers

Driven by 36 papers — median percentile 0. Top paper: “Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer”.

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.49040

N/A

3.5DataRank · unranked

127 citations

Fang‐Shu Ou, Tyler Zemla, Þorvarður R. Hálfdánarson, Heinz‐Josef Lenz, Rimini Breakstone +11 more

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)

The Oncologist(2022)10.1093/oncolo/oyab070

N/A

1.2DataRank · unranked

24 citations

Chao Ma, Sui Zhang, Fang‐Shu Ou, Tiffany M. Bainter, Donna Niedzwiecki +12 more

The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance)

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-19-1454

N/A

0.639DataRank · unranked

11 citations

Sui Zhang, Fang‐Shu Ou, Brian C Mullen, Kimmie Ng, Leonard B. Saltz +14 more

The Utility of Multistate Models: A Flexible Framework for Time-to-Event Data

Current Epidemiology Reports(2022)10.1007/s40471-022-00291-y

N/A

0.633DataRank · unranked

67 citations

Terry M. Therneau, Fang‐Shu Ou, Jennifer Le‐Rademacher

Plant-based diet and survival among patients with metastatic colorectal cancer

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae213

N/A

0.571DataRank · unranked

15 citations

Fang‐Shu Ou, Clare A. Gatten, Chao Ma, Alan P. Venook, Heinz‐Josef Lenz +8 more

ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer

Nature Communications(2022)10.1038/s41467-022-33172-5

N/A

0.550DataRank · unranked

38 citations

Xueping Qu, Chu-Fang Lin, Ling‐Yuh Huw, Avinashnarayan Venkatanarayan, Ethan Sokol +14 more

Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2021

N/A

0.500DataRank · unranked

27 citations

Alexander B. Sibley, Sushant Patil, Amy S. Etheridge, Chen Jiang, Fang‐Shu Ou +15 more

CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007939

N/A

0.416DataRank · unranked

15 citations

Yasmine Baca, Joshua Millstein, Yan Yang, Joanne Xiu, Hiroyuki Arai +24 more

A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations

The Oncologist(2025)10.1093/oncolo/oyaf069

N/A

0.232DataRank · unranked

3 citations

Tyler Zemla, Joleen M. Hubbard, John H. Strickler, Olumide B. Gbolahan, L. R. Wilson +6 more

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad143

N/A

0.165DataRank · unranked

2 citations

Rebecca C. Auer, May Cho, N.A. Dasari, Cynthia Davies-Venn, Cathy Eng +36 more

Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)

Epigenetics(2022)10.1080/15592294.2022.2058225

N/A

0.111DataRank · unranked

1 citations

Ming Yu, Yuhong Zhang, Fang‐Shu Ou, Tyler Zemla, Kelly Carter +8 more

Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3568

N/A

0DataRank · unranked

0 citations

Chao Ma, Fang‐Shu Ou, Chen Yuan, Brendan J. Guercio, Vicente Morales‐Oyarvide +15 more

Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3202

N/A

0DataRank · unranked

22 citations

Akram Yazdani, Naim Rashid, Xueping Qu, Fang‐Shu Ou, Scott Van Buren +7 more

Circulating tumor DNA dynamics on front-line chemotherapy with bevacizumab or cetuximab in metastatic colorectal cancer: A biomarker analysis for acquired genomic alterations in CALGB/SWOG 80405 (Alliance) randomized trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.193

N/A

0DataRank · unranked

4 citations

Fang‐Shu Ou, Alan P. Venook, Federico Innocenti, Ryan Sun, Heinz‐Josef Lenz +2 more

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3586

N/A

0DataRank · unranked

0 citations

Yan Yang, Joshua Millstein, Tadamichi Denda, Fang‐Shu Ou, Federico Innocenti +15 more

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad096

N/A

0DataRank · unranked

9 citations

Thomas A. Hope, Emily B Bergsland, Lisa Bodei, David Bushnell, Jennifer A. Chan +63 more

Data from Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab

(2023)10.1158/1078-0432.c.6532436

N/A

0DataRank · unranked

0 citations

Akram Yazdani, Naim U. Rashid, Xueping Qu, Fang‐Shu Ou, Scott Van Buren +7 more

Data from Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)

(2023)10.1158/1078-0432.c.6529877

Top 100%

0DataRank

Top 100%0 citations

Alexander B. Sibley, Sushant Patil, Amy S. Etheridge, Chen Jiang, Fang‐Shu Ou +15 more

Data from Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)

(2023)10.1158/1078-0432.c.6529877.v1

Top 100%

0DataRank

Top 100%0 citations

Alexander B. Sibley, Sushant Patil, Amy S. Etheridge, Chen Jiang, Fang‐Shu Ou +15 more

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer

European Journal of Cancer(2024)10.1016/j.ejca.2024.113914

N/A

0DataRank · unranked

2 citations

Yan Yang, Yasmine Baca, Joshua Millstein, Tadamichi Denda, Fang‐Shu Ou +27 more

Correction to: Quantitative metrics of bone quality determined at the distal radius using photon‑counting CT

Skeletal Radiology(2024)10.1007/s00256-024-04799-w

N/A

0DataRank · unranked

0 citations

Andrea Ferrero, Kishore Rajendran, Matthew T. Drake, Fang‐Shu Ou, Sharmila Giri +4 more

Quantitative Analysis of Rectal Cancer Biopsies With the Digital Pathology Segmentation Algorithm QuantCRC Associates With Therapy Response and Recurrence

Laboratory Investigation(2025)10.1016/j.labinv.2025.104187

N/A

0DataRank · unranked

3 citations

Cody Eslinger, Kenneth Lee, Lama F. Farchoukh, Daniel Walden, Oluwadunni Emiloju +13 more

Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)

European Journal of Cancer(2025)10.1016/j.ejca.2025.115694

N/A

0DataRank · unranked

1 citations

Bert H. O’Neil, Sebastian Stintzing, Fang‐Shu Ou, Tyler Zemla, Donna Niedzwiecki +18 more

Impact of expression of metabolic genes on patient (pts) outcomes in metastatic colorectal cancer (mCRC): Data from CALGB/SWOG 80405 (Alliance).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.4_suppl.224

N/A

0DataRank · unranked

0 citations

Joshua Millstein, Yan Yang, Karam Ashouri, Shivani Soni, Sandra Algaze +12 more

Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa024

N/A

0DataRank · unranked

13 citations

Sui Zhang, Alan P. Venook, Fang‐Shu Ou, Donna Niedzwiecki, Heinz‐Josef Lenz +15 more

IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa074

N/A

0DataRank · unranked

9 citations

Sui Zhang, Fang‐Shu Ou, Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz +17 more

Guidelines for Statistical Reporting in Medical Journals

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.019

N/A

0DataRank · unranked

28 citations

Jennifer Le‐Rademacher, Karla V. Ballman, Alex A. Adjei, Sumithra J. Mandrekar, Fang‐Shu Ou

Quantile regression models for current status data

UNC Libraries(2020)10.17615/32ec-y086

N/A

0DataRank · unranked

0 citations

Jianwen Cai, Fang‐Shu Ou, Zeng, Donglin

Biomarker Discovery and Validation: Statistical Considerations

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.01.1616

N/A

0DataRank · unranked

238 citations

Stefan Michiels, Yu Shyr, Alex A. Adjei, Ann L. Oberg, Fang‐Shu Ou

Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab200

N/A

0DataRank · unranked

45 citations

Sui Zhang, Fang‐Shu Ou, Chao Ma, Nadine J. McCleary, Donna Niedzwiecki +16 more

Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931)

Cancer(2021)10.1002/cncr.33649

N/A

0DataRank · unranked

14 citations

Jun He, Jennifer Le‐Rademacher, Fang‐Shu Ou, Andrew Dodge, Tyler Zemla +8 more

Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)

JNCI Cancer Spectrum(2021)10.1093/jncics/pkab034

N/A

0DataRank · unranked

7 citations

Sui Zhang, Chao Ma, Fang‐Shu Ou, Eric Wolfe, Shuji Ogino +16 more

Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials

Contemporary Clinical Trials Communications(2021)10.1016/j.conctc.2021.100827

N/A

0DataRank · unranked

2 citations

Jun Tang, Ming‐Wen An, Sumithra J. Mandrekar, Fang‐Shu Ou

Dietary fat in relation to overall and progression-free survival among patients (pts) with advanced or metastatic colorectal cancer (CRC): Data from CALGB 80405 (Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3588

N/A

0DataRank · unranked

0 citations

Chao Ma, Fang‐Shu Ou, Alan P. Venook, Kimmie Ng, Donna Niedzwiecki +12 more

Immune signatures to affect overall survival (OS) and response to bevacizumab (Bev) or cetuximab (Cet) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3515

N/A

0DataRank · unranked

0 citations

Akram Yazdani, Xueping Qu, Fang‐Shu Ou, Scott Van Buren, Omar Kabbarah +5 more

Fang‐Shu Ou

Indexed papers

Top data-sharing exemplar

Papers